JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258813

Human CEP57 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

CEP57 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 50 bp deletion in exon1 and Insertion of the selection cassette in exon1.
3 Images
Sanger Sequencing - Human CEP57 knockout HeLa cell lysate (AB258813)
  • Sanger seq

Unknown

Sanger Sequencing - Human CEP57 knockout HeLa cell lysate (AB258813)

Allele-2 : Insertion of the selection cassette in exon1

Sanger Sequencing - Human CEP57 knockout HeLa cell lysate (AB258813)
  • Sanger seq

Unknown

Sanger Sequencing - Human CEP57 knockout HeLa cell lysate (AB258813)

Allele-3 : Insertion of the selection cassette in exon1

Sanger Sequencing - Human CEP57 knockout HeLa cell lysate (AB258813)
  • Sanger seq

Unknown

Sanger Sequencing - Human CEP57 knockout HeLa cell lysate (AB258813)

Allele-1 : 50 bp deletion in exon1

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 50 bp deletion in exon1 and Insertion of the selection cassette in exon1.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258813-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human CEP57 knockout HeLa cell lysate", "number":"AB258813-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258813-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
CEP57
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CEP57 also known as Centrosomal Protein 57 or Translokin is a protein with a molecular mass of approximately 57 kDa. CEP57 plays an important mechanical role in the centrosome which is important for the organization of microtubules during cell division. This protein localizes in the centrosome area within the cell cytoplasm. Expression of CEP57 is widespread occurring in various tissues which suggests its function is significant in different cellular contexts.
Biological function summary

CEP57 is important for proper cell division and spindle pole formation. It interacts within a complex of centrosomal proteins playing roles in microtubule nucleation and stabilization. CEP57 also functions as a microtubule-binding protein aiding the accurate segregation of chromosomes during mitosis. By stabilizing microtubule-kinetochore attachments CEP57 ensures effective chromosomal distribution hence maintaining genomic integrity and preventing potential cellular abnormalities.

Pathways

CEP57 contributes significantly to the cell cycle and mitotic spindle organization pathways. It works alongside other centrosomal proteins such as CEP192 and γ-tubulin enhancing their interaction and stabilization of microtubules. CEP57 is also linked to the microtubule-organizing center integrating into pathways important for cell division and duplication processes which are central to maintaining cellular homeostasis and function.

Researchers have associated CEP57 with certain cancers and mosaic variegated aneuploidy syndrome. In cancer overexpression or altered function of CEP57 might lead to improper cell division contributing to tumorigenesis. Furthermore in mosaic variegated aneuploidy syndrome improper function of CEP57 leads to chromosomal instability and abnormal cell growth. CEP57 involvement in these diseases highlights its interactions with other proteins such as TP53 which also manages cell cycle regulation and genomic stability.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com